PI-RR:前列腺癌放疗或根治性前列腺切除术后局部复发的MRI评估报告系统综述
本文综述了2021年发布的PI-RR系统,该系统为国际共识指南,用于多参数MRI检测放疗或根治性前列腺切除术后局部复发前列腺癌的采集、解读和报告。系统通过标准化结构化报告方法,将复发总体怀疑度分为5分制,该评分由DWI和DCE的5分制评分衍生,并分别针对放疗后和根治性切除术后提供量表。初步回顾性研究显示PI-RR在检测局部复发肿瘤方面具有可重复性和准确性的良好结果。
要点
- PI-RR采用5分制总体怀疑度评分,由DWI和DCE各自的5分制评分衍生。
- 放疗后与根治性切除术后分别有独立的DWI和DCE评分量表。
- T2WI也采用5分制评估但仅用于解剖成像,不影响总体评分。
核心结论
- PI-RR系统通过标准化结构化报告减少变异,初步回顾性研究显示其在检测局部复发肿瘤方面具有可重复性和准确性的良好结果。
研究设计与样本
- 本文为综述,回顾PI-RR系统的临床应用,该系统为2021年发布的国际共识指南,针对放疗或根治性前列腺切除术后多参数MRI检测局部复发。
- 原文未报告具体样本量、中心数、设备/序列细节及参考标准。
关键影像表现/征象
- DWI和DCE成像分别采用5分制量表评估,量表考虑检测到的异常与治疗前成像原发肿瘤位置的关系。
- T2加权成像也采用5分制评估,用于解剖成像但不影响总体评分。
诊断标准与关键数值
- 总体复发怀疑度分为5分制,由DWI和DCE的5分制评分衍生。
- 放疗后和根治性前列腺切除术后分别提供DWI和DCE的独立5分制量表。
- 原文未报告敏感度、特异度、AUC、阈值等具体数值。
临床应用与阅片要点
- 日常阅片应采用PI-RR结构化报告,按5分制分别评估DWI和DCE并衍生总体怀疑度评分。
- 需根据治疗方式(放疗后或根治性切除术后)选用对应的DWI和DCE量表。
- 评估异常时应结合治疗前成像原发肿瘤位置判断关系。
- T2WI可用于解剖定位但不参与总体评分。
局限性
- 原文未明确列出局限性;本文为综述,所引初步研究为回顾性设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
The purpose of this article is to review clinical application of the Prostate Imaging for Recurrence Reporting (PI-RR) system. This system, released in 2021, represents international consensus-based guidelines for the acquisition, interpretation, and reporting of multiparametric MRI performed to detect locally recurrent prostate cancer after radiation therapy or radical prostatectomy. The system reduces variability through use of a standardized and structured reporting approach whereby the overall level of suspicion of recurrence is classified on a 5-point scale. The overall suspicion score is derived from 5-point scales for assessing DWI and dynamic contrast-enhanced (DCE) imaging. Separate scales for both DWI and DCE imaging are provided for evaluation after radiation therapy and after radical prostatectomy. These scales account for the relation between detected abnormalities and the location of the primary tumor on pretreatment imaging. T2-weighted imaging is also assessed on a 5-point scale and is useful for anatomic imaging but does not influence the overall score. Initial retrospective studies have shown promising results with respect to the reproducibility and accuracy of PI-RR in detecting locally recurrent tumor.
引用
- Abreu-Gomez, Dias, Ghai, et al. PI-RR: The Prostate Imaging for Recurrence Reporting System for MRI Assessment of Local Prostate Cancer Recurrence After Radiation Therapy or Radical Prostatectomy-A Review. AJR Am J Roentgenol. 2023. PMID: 36722763. doi:10.2214/AJR.22.28665
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。